The (After)life of a Trial: Biocommunicability of an At-Risk Pregnancy

Ashish Premkumar*, Whitney B. You

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


The publication of A Randomized Trial of Induction Versus Expectant Management (ARRIVE), conducted in the United States in 2018, heralded a paradigm shift within the obstetrical management of term pregnancy among people who have not previously given birth. ARRIVE finds its home among other canonical–and controversial–randomized controlled trials (RCTs) within obstetrics. We argue that RCTs have their own (after)life, both creating new subjects for biomedical intervention and recalibrating who reproductive health practitioners consider to be at risk of adverse health outcomes. These data have important consequences for medical social scientific engagement with RCTs to further interrogate the questions of risk and intervention within reproductive health.

Original languageEnglish (US)
Pages (from-to)794-809
Number of pages16
JournalMedical Anthropology: Cross Cultural Studies in Health and Illness
Issue number8
StatePublished - 2022


  • Term Breech
  • United States
  • breech presentation
  • induction of labor
  • randomized controlled trial

ASJC Scopus subject areas

  • Health(social science)
  • Anthropology


Dive into the research topics of 'The (After)life of a Trial: Biocommunicability of an At-Risk Pregnancy'. Together they form a unique fingerprint.

Cite this